Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,192 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

NCT01897480

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Herlev and Gentofte Hospital Herlev, Capital Region, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense Universitetshospital Odense C, Syd, Denmark
  • CHU de Caen Hopital Cote de Nacre Caen, France
View all 45 locations
View Trial Details
Completed

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

NCT03003468

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Completed

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

NCT03285321

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
  • University of Louisville James Graham Brown Cancer Center Louisville, Kentucky, United States
View Trial Details
Completed

A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)

NCT00596648

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of California, Davis Sacramento, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Completed

A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

NCT04452877

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Novartis Investigative Site Harbin, Heilongjiang, China
  • Novartis Investigative Site Changsha, Hunan, China
  • Novartis Investigative Site Chengdu, Sichuan, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
View Trial Details

Related conditions